Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | CDA | P32320 | 7/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.41 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.41 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.41 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.41 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.41 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.41 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19317500 | 0.71 | LGALS1 (0.59) | LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL15314105 | 0.71 | LGALS1 (0.59) | LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL5452516 | 0.71 | LGALS1 (0.59) | LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL24115372 | 0.71 | LGALS1 (0.59) | LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL5452134 | 0.71 | LGALS1 (0.59) | LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL24243426 | 0.71 | LGALS1 (0.59) | LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL13632537 | 0.71 | LGALS1 (0.59) | LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL13197776 | 0.71 | LGALS1 (0.59) | LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL4439225 | 0.71 | LGALS1 (0.59) | LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL17931796 | 0.71 | LGALS1 (0.59) | LGALS1LGALS3LGALS9LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8003769-B2 | Dye-labeled ribonucleotide triphosphates | APPLIED BIOSYSTEMS, LLC (US) | 2011-08-23 | — | — | US | disclosed |
| US-20100292457-A1 | Dye-labeled ribonucleotide triphosphates | APPLIED BIOSYSTEMS, LLC (US) | 2010-11-18 | — | — | US | disclosed |
| US-7678892-B2 | Dye-labeled ribonucleotide triphosphates | APPLIED BIOSYSTEMS, LLC (US) | 2010-03-16 | — | — | US | disclosed |
| US-20070293662-A1 | Dye-labeled ribonucleotide triphosphates | APPLERA CORPORATION (US) | 2007-12-20 | — | — | US | disclosed |
| US-7262029-B2 | Dye-labeled ribonucleotide triphosphates | APPLERA CORPORATION (US) | 2007-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292457-A1 | Dye-labeled ribonucleotide triphosphates | DUT, POLRMT, SAMHD1 | CDK1 2394/4885CDA 183/4885MAPT 3687/4885 |
| US-20070293662-A1 | Dye-labeled ribonucleotide triphosphates | DUT, POLRMT, SAMHD1 | CDK1 2394/4885CDA 183/4885MAPT 3687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.